These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

263 related articles for article (PubMed ID: 28633698)

  • 1. Feasibility of a streamlined tuberculosis diagnosis and treatment initiation strategy.
    Shete PB; Nalugwa T; Farr K; Ojok C; Nantale M; Howlett P; Haguma P; Ochom E; Mugabe F; Joloba M; Chaisson LH; Dowdy DW; Moore D; Davis JL; Katamba A; Cattamanchi A
    Int J Tuberc Lung Dis; 2017 Jul; 21(7):746-752. PubMed ID: 28633698
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tuberculosis treatment outcomes among people living with HIV diagnosed using Xpert MTB/RIF versus sputum-smear microscopy in Botswana: a stepped-wedge cluster randomised trial.
    Agizew T; Chihota V; Nyirenda S; Tedla Z; Auld AF; Mathebula U; Mathoma A; Boyd R; Date A; Pals SL; Lekone P; Finlay A
    BMC Infect Dis; 2019 Dec; 19(1):1058. PubMed ID: 31842773
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of the Xpert MTB/RIF assay for the diagnosis of smear-negative pulmonary and extrapulmonary tuberculosis in Madagascar.
    Rakotoarivelo R; Ambrosioni J; Rasolofo V; Raberahona M; Rakotosamimanana N; Andrianasolo R; Ramanampamonjy R; Tiaray M; Razafimahefa J; Rakotoson J; Randria M; Bonnet F; Calmy A;
    Int J Infect Dis; 2018 Apr; 69():20-25. PubMed ID: 29408360
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of replacing smear microscopy with Xpert MTB/RIF for diagnosing tuberculosis in Brazil: a stepped-wedge cluster-randomized trial.
    Durovni B; Saraceni V; van den Hof S; Trajman A; Cordeiro-Santos M; Cavalcante S; Menezes A; Cobelens F
    PLoS Med; 2014 Dec; 11(12):e1001766. PubMed ID: 25490549
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of the Xpert MTB/RIF assay for the diagnosis of pulmonary tuberculosis in a high HIV prevalence setting.
    Theron G; Peter J; van Zyl-Smit R; Mishra H; Streicher E; Murray S; Dawson R; Whitelaw A; Hoelscher M; Sharma S; Pai M; Warren R; Dheda K
    Am J Respir Crit Care Med; 2011 Jul; 184(1):132-40. PubMed ID: 21493734
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of sputum quality and volume on the yield of bacteriologically-confirmed TB by Xpert MTB/RIF and smear.
    Zimba O; Tamuhla T; Basotli J; Letsibogo G; Pals S; Mathebula U; Mathoma A; Serumola C; Ramogale K; Boyd R; Tran T; Finlay A; Auld A; Date A; Alexander H; Chihota V; Agizew T
    Pan Afr Med J; 2019; 33():110. PubMed ID: 31489088
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of gene xpert for routine diagnosis of HIV-associated tuberculosis in Nigeria: A prospective cohort study.
    Akanbi MO; Achenbach C; Taiwo B; Idoko J; Ani A; Isa Y; Agbaji O; Ukoli C; Akande P; Maiga M; Murphy RL
    BMC Pulm Med; 2017 May; 17(1):87. PubMed ID: 28558662
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of OMNIgene®•SPUTUM-stabilised sputum for long-term transport and Xpert® MTB/RIF testing in Nepal.
    Maharjan B; Kelly-Cirino CD; Weirich A; Curry PS; Hoffman H; Avsar K; Shrestha B
    Int J Tuberc Lung Dis; 2016 Dec; 20(12):1661-1667. PubMed ID: 28000586
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Point-of-care Xpert® MTB/RIF for smear-negative tuberculosis suspects at a primary care clinic in South Africa.
    Van Rie A; Page-Shipp L; Hanrahan CF; Schnippel K; Dansey H; Bassett J; Clouse K; Scott L; Stevens W; Sanne I
    Int J Tuberc Lung Dis; 2013 Mar; 17(3):368-72. PubMed ID: 23407225
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased detection of smear-negative pulmonary tuberculosis by GeneXpert MTB/RIF® assay after bleach concentration.
    Tadesse M; Aragaw D; Rigouts L; Abebe G
    Int J Mycobacteriol; 2016 Jun; 5(2):211-8. PubMed ID: 27242234
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Added value of molecular assay Xpert MTB/RIF compared to sputum smear microscopy to assess the risk of tuberculosis transmission in a low-prevalence country.
    Opota O; Senn L; Prod'hom G; Mazza-Stalder J; Tissot F; Greub G; Jaton K
    Clin Microbiol Infect; 2016 Jul; 22(7):613-9. PubMed ID: 27139592
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assessment of the sensitivity and specificity of Xpert MTB/RIF assay as an early sputum biomarker of response to tuberculosis treatment.
    Friedrich SO; Rachow A; Saathoff E; Singh K; Mangu CD; Dawson R; Phillips PP; Venter A; Bateson A; Boehme CC; Heinrich N; Hunt RD; Boeree MJ; Zumla A; McHugh TD; Gillespie SH; Diacon AH; Hoelscher M;
    Lancet Respir Med; 2013 Aug; 1(6):462-70. PubMed ID: 24429244
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Testing Pooled Sputum with Xpert MTB/RIF for Diagnosis of Pulmonary Tuberculosis To Increase Affordability in Low-Income Countries.
    Abdurrahman ST; Mbanaso O; Lawson L; Oladimeji O; Blakiston M; Obasanya J; Dacombe R; Adams ER; Emenyonu N; Sahu S; Creswell J; Cuevas LE
    J Clin Microbiol; 2015 Aug; 53(8):2502-8. PubMed ID: 26019204
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical predictors and accuracy of empiric tuberculosis treatment among sputum smear-negative HIV-infected adult TB suspects in Uganda.
    Nakiyingi L; Bwanika JM; Kirenga B; Nakanjako D; Katabira C; Lubega G; Sempa J; Nyesiga B; Albert H; Manabe YC
    PLoS One; 2013; 8(9):e74023. PubMed ID: 24040151
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Performance of the Xpert® MTB/RIF assay in an active case-finding strategy: a pilot study from Tanzania.
    Ntinginya EN; Squire SB; Millington KA; Mtafya B; Saathoff E; Heinrich N; Rojas-Ponce G; Kowuor D; Maboko L; Reither K; Clowes P; Hoelscher M; Rachow A
    Int J Tuberc Lung Dis; 2012 Nov; 16(11):1468-70. PubMed ID: 22964006
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Upfront Xpert MTB/RIF testing on various specimen types for presumptive infant TB cases for early and appropriate treatment initiation.
    Raizada N; Khaparde SD; Rao R; Kalra A; Sarin S; Salhotra VS; Swaminathan S; Khanna A; Chopra KK; Hanif M; Singh V; Umadevi KR; Nair SA; Huddart S; Tripathi R; Surya Prakash CH; Saha BK; Denkinger CM; Boehme C
    PLoS One; 2018; 13(8):e0202085. PubMed ID: 30161142
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Burden of tuberculosis in intensive care units in Cape Town, South Africa, and assessment of the accuracy and effect on patient outcomes of the Xpert MTB/RIF test on tracheal aspirate samples for diagnosis of pulmonary tuberculosis: a prospective burden of disease study with a nested randomised controlled trial.
    Calligaro GL; Theron G; Khalfey H; Peter J; Meldau R; Matinyenya B; Davids M; Smith L; Pooran A; Lesosky M; Esmail A; Miller MG; Piercy J; Michell L; Dawson R; Raine RI; Joubert I; Dheda K
    Lancet Respir Med; 2015 Aug; 3(8):621-30. PubMed ID: 26208996
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Investigation of OMNIgene·SPUTUM performance in delayed tuberculosis testing by smear, culture, and Xpert MTB/RIF assays in Uganda.
    Kelly-Cirino CD; Musisi E; Byanyima P; Kaswabuli S; Andama A; Sessolo A; Sanyu I; Zawedde J; Curry PS; Huang L
    J Epidemiol Glob Health; 2017 Jun; 7(2):103-109. PubMed ID: 28413105
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Accuracy of giant African pouched rats for diagnosing tuberculosis: comparison with culture and Xpert
    Mulder C; Mgode GF; Ellis H; Valverde E; Beyene N; Cox C; Reid SE; Van't Hoog AH; Edwards TL
    Int J Tuberc Lung Dis; 2017 Nov; 21(11):1127-1133. PubMed ID: 29037292
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of molecular and immunological methods for the rapid diagnosis of smear-negative tuberculosis.
    Jafari C; Ernst M; Kalsdorf B; Lange C
    Int J Tuberc Lung Dis; 2013 Nov; 17(11):1459-65. PubMed ID: 24125451
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.